相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Genomic heterogeneity in multiple myeloma
Raphael Szalat et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2015)
MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib
Z. Xie et al.
LEUKEMIA (2015)
Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma
Deepti Soodgupta et al.
MOLECULAR CANCER THERAPEUTICS (2015)
MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
Toril Holien et al.
ONCOTARGET (2015)
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy
George Mulligan et al.
BLOOD (2014)
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Jens G. Lohr et al.
CANCER CELL (2014)
Inhibition of KIF22 suppresses cancer cell proliferation by delaying mitotic exit through upregulating CDC25C expression
Yue Yu et al.
CARCINOGENESIS (2014)
Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma
Timothy R. Rosean et al.
IMMUNOLOGIC RESEARCH (2014)
Comparison of RNA-Seq and Microarray in Transcriptome Profiling of Activated T Cells
Shanrong Zhao et al.
PLOS ONE (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
MMSET is the key molecular target in t(4;14) myeloma
F. Mirabella et al.
BLOOD CANCER JOURNAL (2013)
A gene expression signature for high-risk multiple myeloma
R. Kuiper et al.
LEUKEMIA (2012)
The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies
A. Kalff et al.
BLOOD CANCER JOURNAL (2012)
The genetic architecture of multiple myeloma
Gareth J. Morgan et al.
NATURE REVIEWS CANCER (2012)
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
Eva Martinez-Garcia et al.
BLOOD (2011)
MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin
Tricia Nardiello et al.
CLINICAL CANCER RESEARCH (2011)
A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
Jerome Moreaux et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Targeting the IL-6 Pathway in Multiple Myeloma and its Implications in Cancer-Associated Gene Hypermethylation
Susan Blaydes Ingersoll et al.
Medicinal Chemistry (2011)
Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
Annemiek Broyl et al.
BLOOD (2010)
RNA-Seq: a revolutionary tool for transcriptomics
Zhong Wang et al.
NATURE REVIEWS GENETICS (2009)
Signalling through C-type lectin receptors: shaping immune responses
Teunis B. H. Geijtenbeek et al.
NATURE REVIEWS IMMUNOLOGY (2009)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks
MRJ Carlson et al.
BMC GENOMICS (2006)
Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis
H Ishii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Orc6 involved in DNA replication, chromosome segregation, and cytokinesis
SG Prasanth et al.
SCIENCE (2002)
分享论文
